NDC 70771-1783-01 - Theophylline
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1783
- Requested NDC
- 70771-1783-01
- Package NDCs from labels
- 70771-1783-1, 70771-1783-01
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Theophylline - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1783-1 | Theophylline | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1783 | THEOPHYLLINE TABLET, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED] | 1 | Current NDC, 1 package rows | 20240528_7339f98d-b996-4e20-a7a7-315fd2a9fa4d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HEB Advanced Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | HEB Grocery Company, LP | f76281d6-3aea-349b-e053-6394a90afca2 | 2023-12-20 | Warnings | FZ989GH94E |
| Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Proficient Rx LP | 73e12596-6dd5-4cd2-83ed-992e1211b4b8 | 2023-12-01 | Warnings | FZ989GH94E |
| Theophylline | THEOPHYLLINE | Bionpharma Inc., | 63517422-45a0-4e78-8505-eca054068ee9 | 2023-10-12 | Warnings, Adverse reactions | 317769 0I55128JYK |
| Theophylline | THEOPHYLLINE | Camber Pharmaceuticals, Inc. | bf320619-c53b-49a7-97b5-cd0c075a9f75 | 2023-09-20 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
| Theophylline | THEOPHYLLINE | Alembic Pharmaceuticals Limited | 31f3c720-1597-4d43-9296-33017b90b15f | 2023-01-11 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
| Theophylline | THEOPHYLLINE | Teva Pharmaceuticals, Inc. | 25eabefa-518b-4030-9b72-01ac8b3deba9 | 2022-04-01 | Warnings, Adverse reactions | 317769 314241 |
| Theophylline | THEOPHYLLINE | Alembic Pharmaceuticals Inc. | 77e849b8-900b-4f0d-ac5c-1391abcd5721 | 2021-10-01 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.